Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Acacia Research Subsidiary Presents New Biochip Technology at American Peptide Symposium.


PASADENA, Calif.--(BUSINESS WIRE)--July 13, 1999--

Acacia Research Corp. (Nasdaq/NM:ACRI) Tuesday reported that its subsidiary CombiMatrix Corp. presented information at the 16th Annual American Peptide Symposium held in Minneapolis demonstrating the company's ability to synthesize peptides on its proprietary biochip biochip

Small-scale device, analogous to an integrated circuit, constructed of or used to analyze organic molecules associated with living organisms. One type of theoretical biochip is a small device constructed of large organic molecules, such as proteins, and capable of
.

The CombiMatrix biochip system integrates the miniaturization min·i·a·tur·ize  
tr.v. min·i·a·tur·ized, min·i·a·tur·iz·ing, min·i·a·tur·iz·es
To plan or make on a greatly reduced scale.



min
 of semiconductors with new developments in biotechnology and chemistry. The company's core technology utilizes a unique buffering system to create "virtual reactors" -- tiny chemical flasks the size of a human hair, that are separated from each other without glass walls.

The CombiMatrix technology synthesizes DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
, peptides and other chemicals in these miniaturized electrochemical electrochemical /elec·tro·chem·i·cal/ (-kem´i-k'l) pertaining to interaction or interconversion of chemical and electrical energies.

e·lec·tro·chem·i·cal
adj.
 flasks on a tiny semiconductor chip.

The biochips are inexpensively produced on existing semiconductor fabrication lines. This eliminates the need for expensive photomasks or robots at CombiMatrix, and reduces the investment in capital equipment and clean rooms at the company. CombiMatrix's unique biochip system may offer significant advantages over current products on the market.

Acacia Research has a 53 percent equity ownership in CombiMatrix, which is located in Burlingame, Calif.

Acacia Research Corp. is a diversified company diversified company

A company engaged in varied business operations not directly related to one another. A diversified company is less likely to suffer either a collapse or a spectacular gain in earnings compared with a firm concentrating its operations in a
 with interests in several enterprises -- CombiMatrix Corp. (biochips/drug discovery technology), Greenwich Information Technologies LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 (video and audio-on-demand technology), MerkWerks Corp. (software development), Signature-mail.com llc (personalized e-mail service), Soundbreak.com Inc. (Internet music and e-commerce), Soundview Technologies Inc. (V-chip technology), Whitewing Labs Inc. (marketer of nutritional supplements), and Acacia Capital Management (investment advisory services).
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 13, 1999
Words:235
Previous Article:Tyco Terminates Discussions With Williams Plc.
Next Article:Active Traders Network Announces Investment Opinion; Focus on Online Trader Education.



Related Articles
Acacia Research Subsidiary Awarded Department of Defense Contract.
Acacia Research Subsidiary Awarded Second Government Contract; Department of Energy Awards SBIR for Analysis of Gene Products.
Acacia Research Subsidiary Completes $4 Million Private Equity Financing.
CombiMatrix Corporation Completes $4 Million Private Equity Financing.
Acacia Research Affiliate Awarded Department of Defense Grant.
Acacia Research Affiliate CombiMatrix Raises $17.5 Million in Equity Financing.
CombiMatrix to Present At Bear Stearns Annual Healthcare Conference and J.P. Morgan H&Q's Annual Genomics Conference.
CombiMatrix To Present at UBS Warburg Global Sciences Conference.
CombiMatrix Presentation at UBS Warburg Conference Available Via Telephone.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles